TERT and cancer: A recent pan-cancer study which included sequencing of n = 796 urothelial cancers confirmed high frequencies (>70%) of TERT promoter mutations in urothelial carcinomas of the urinary bladder and the urethra and a slightly reduced prevalence in upper tract urothelial cancers (53%) [18].